Director, Drug Development AI Nexus Decision Integration Lead

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits.

This is work that transforms the lives of patients, and the careers of those who do it.

The Director, Drug Development AI Nexus Decision Integration Lead is a newly created leadership role at the intersection of drug development, artificial intelligence, and operating model transformation. This individual will serve as the primary bridge between Drug Development, Research and the AI Nexus team, translating strategic priorities, business requirements, and decision‑making needs into AI‑enabled workflows, governance processes, data requirements, and platform capabilities that improve the quality, speed, and consistency of development decisions.

Positioned within Drug Development Excellence (DDE), this role has broad cross‑functional reach across Drug Development and plays a critical role in advancing BMS's vision for AI‑enabled decision‑making. The scope extends beyond the integration of AI Nexus into Global Program Teams (GPTs) to encompass portfolio‑level decision workflows, governance cadences, and the broader agentic intelligence ecosystem being established across R&D. Working in close partnership with BI&T, Research, and functional leaders, the role will drive strategic prioritization, workflow redesign, AI‑data readiness, adoption, and organizational change to enable new ways of working.

The ideal candidate is a credible drug development leader who can bridge the worlds of science, operations, and technology. They possess a deep understanding of how development decisions are made and can translate complex business needs into scalable, AI‑enabled solutions by partnering effectively with business, data, and technology teams. They are equally comfortable discussing portfolio strategy, development planning, phase transitions, governance processes, data architecture, and emerging AI capabilities, and they can connect these domains to deliver measurable business impact.

Success in this role requires strategic thinking, creativity, influence without authority, and the ability to inspire and mobilize cross‑functional teams toward AI‑native ways of working.

• Translate Drug Development strategic priorities, business requirements, and decision‑making needs into scalable business capabilities, AI‑enabled workflows, data requirements, and AI Nexus roadmap priorities.
• Serve as the Drug Development anchor for the AI Nexus platform, translating the AI Nexus vision into executable workflows embedded directly in Global Program Teams (GPTs) and governance forums.
• Map, prioritize, and redesign key Drug Development decision points — from Phase transition and regulatory milestone reviews to portfolio‑level governance — to leverage AI Nexus‑enabled evidence, agentic analysis, and learning loops.
• Partner with AI Nexus Product Leadership (BI&T) and Platform Engineering teams to communicate Drug Development decision needs and ensure the platform is built and iterated to serve them.
• Operate as an “embedded translator” between Drug Development operational and clinical needs and AI Nexus technical capabilities — converting ambiguous decision problems into structured, AI‑ready workflow requirements with defined data requirements.

• Drive AI Nexus adoption across Drug Development through demonstrated value in live GPTs and culture‑driven change management — not through mandates or training‑first approaches.
• Build and sustain a network of Drug Development champions, GPT leads, and functional stakeholders who actively use and shape Nexus workflows.
• Develop and execute adoption strategies tailored to Drug Development archetypes — study teams, clinicians, program leaders, and executive leaders —…